Log off SitemapDisclaimer

The membrane controlled release patch Matrifen® with fentanyl eases your pain

The membrane controlled release patch Matrifen® from Nycomed provides pain relief for patients with severe chronic pain.

Membrane controlled release - Matrifen® by NycomedMatrifen® with membrane controlled release provides relief in patients with chronic pain.

>> Information on Matrifen® with membrane controlled release

Matrifen® is a transdermal patch with membrane controlled release. It is a 72 hour or 3 day patch with a skin friendly silicone adhesion layer, that sticks well to the surface of the skin.

The efficient and advanced matrix fentanyl patch technology provides pain relief for cancer related as well as non cancer related pains and the lower drug load adds to a higher degree of safety and lower environmental burden.

About Nycomed
Nycomed is driving a new way of providing pharmaceutical products in Europe. Physicians are seeking new treatments that make a clear medical difference. But traditional pharmaceutical companies, with a single research department, are finding it harder to meet this need.

Nycomed, by contrast, can access the work of thousands of companies dedicated to research, and choose to make available the most innovative treatments.

Special features

To access the site you must confirm being a healthcare professional - use the link on the left side of this page

Mode of action video

An animation presenting the Matrifen® patch;
- Application
- Mode of action

Additional material

- Product details
- Pharmacokinetics
- Technical profile
Conversion tables for download 

- Oral morphine to Matrifen (100:1)
- Oral morphine to Matrifen (150:1)
- Potency table